NCT00001203View on ClinicalTrials.gov

Deferoxamine for the Treatment of Hemochromatosis

CompletedOBSERVATIONAL
Enrollment

151

Participants

Timeline

Start Date

April 22, 1985

Study Completion Date

November 9, 2015

Conditions
Diabetes MellitusHeart DiseaseHemochromatosisThalassemia
Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00001203 - Deferoxamine for the Treatment of Hemochromatosis | Biotech Hunter | Biotech Hunter